Cargando…
581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee
BACKGROUND: In December 2020, SARS-CoV-2 vaccines were made available to healthcare workers and soon thereafter offered to the general public according to age and risk of severe illness. Despite widespread access, vaccination rates vary by region, with Tennessee ranking lower than the national avera...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644308/ http://dx.doi.org/10.1093/ofid/ofab466.779 |
_version_ | 1784610055378698240 |
---|---|
author | Fernandez, Kailee N Rankin, Danielle A Howe, Harrison L Bloos, Sean M Salib, Seifein Talj, Rana Rahman, Herdi Kurnia Waqfi, Danya Villarreal, Jessica Yanis, Ahmad Howard, Leigh Chappell, James Halasa, Natasha B Halasa, Natasha B |
author_facet | Fernandez, Kailee N Rankin, Danielle A Howe, Harrison L Bloos, Sean M Salib, Seifein Talj, Rana Rahman, Herdi Kurnia Waqfi, Danya Villarreal, Jessica Yanis, Ahmad Howard, Leigh Chappell, James Halasa, Natasha B Halasa, Natasha B |
author_sort | Fernandez, Kailee N |
collection | PubMed |
description | BACKGROUND: In December 2020, SARS-CoV-2 vaccines were made available to healthcare workers and soon thereafter offered to the general public according to age and risk of severe illness. Despite widespread access, vaccination rates vary by region, with Tennessee ranking lower than the national average. Therefore, we aimed to survey adults in greater Nashville, TN regarding SARS-CoV-2 vaccine perceptions. METHODS: We conducted a cross-sectional study of an ongoing longitudinal cohort of individuals with confirmed and/or suspected SARS-CoV-2 infection and their household contacts with enrollment onset in March 2020. For this analysis, individuals were included if they were ≥ 18 years and available for a one-year follow-up visit. At the one-year visit individuals completed a survey about vaccine preferences, beliefs and risks. Demographic and social characteristics were collected at enrollment. Individuals were considered vaccinated if they had received at least one dose of a SARS-CoV-2 vaccine under FDA emergency use authorization. Vaccine perceptions were compared by SARS-CoV-2-infection and vaccination status using Pearson’s chi-squared, alpha=5%. RESULTS: Between April-May 2021, 115 individuals completed the one-year follow-up. Table 1 includes sociodemographic characteristics of adults, of which the majority were vaccinated and were unemployed or in non-essential occupations. Most individuals agreed the SARS-CoV-2 vaccine can prevent infection and hospitalization (Figure 1A & B). Unvaccinated participants more often agreed that those who contracted SARS-CoV-2 should not receive the vaccine (30%), whereas vaccinated persons less often agreed (11%, p< 0.001) (Figure 1A). Additionally, 44% of unvaccinated individuals were neutral or disagreed that benefits of SARS-CoV-2 vaccination outweighed the illness risk, compared to 10% in the vaccinated group, p=0.001 (Figure 1A). Minimal differences of vaccine perceptions were observed between SARS-CoV-2 positive and negative adults (Figure 1B). Table 1. Sociodemographic Characteristics of Adults [Image: see text] Figure 1. Vaccine perceptions of vaccinated and unvaccinated (A) SARS-CoV-2 positive and SARS-CoV-2 negative (B) adults in greater Nashville, TN. Vaccine perceptions were collected through a standardized survey at the one-year visit. [Image: see text] CONCLUSION: Although some unvaccinated individuals seemingly perceived the SARS-CoV-2 vaccine offered some protection, research should continue to evaluate the implications of vaccine hesitancy on the COVID-19 pandemic response as we prepare for the upcoming respiratory season. DISCLOSURES: Natasha B. Halasa, MD, MPH, Genentech (Other Financial or Material Support, I receive an honorarium for lectures - it's a education grant, supported by genetech)Quidel (Grant/Research Support, Other Financial or Material Support, Donation of supplies/kits)Sanofi (Grant/Research Support, Other Financial or Material Support, HAI/NAI testing) Natasha B. Halasa, MD, MPH, Genentech (Individual(s) Involved: Self): I receive an honorarium for lectures - it's a education grant, supported by genetech, Other Financial or Material Support, Other Financial or Material Support; Sanofi (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support |
format | Online Article Text |
id | pubmed-8644308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86443082021-12-06 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee Fernandez, Kailee N Rankin, Danielle A Howe, Harrison L Bloos, Sean M Salib, Seifein Talj, Rana Rahman, Herdi Kurnia Waqfi, Danya Villarreal, Jessica Yanis, Ahmad Howard, Leigh Chappell, James Halasa, Natasha B Halasa, Natasha B Open Forum Infect Dis Poster Abstracts BACKGROUND: In December 2020, SARS-CoV-2 vaccines were made available to healthcare workers and soon thereafter offered to the general public according to age and risk of severe illness. Despite widespread access, vaccination rates vary by region, with Tennessee ranking lower than the national average. Therefore, we aimed to survey adults in greater Nashville, TN regarding SARS-CoV-2 vaccine perceptions. METHODS: We conducted a cross-sectional study of an ongoing longitudinal cohort of individuals with confirmed and/or suspected SARS-CoV-2 infection and their household contacts with enrollment onset in March 2020. For this analysis, individuals were included if they were ≥ 18 years and available for a one-year follow-up visit. At the one-year visit individuals completed a survey about vaccine preferences, beliefs and risks. Demographic and social characteristics were collected at enrollment. Individuals were considered vaccinated if they had received at least one dose of a SARS-CoV-2 vaccine under FDA emergency use authorization. Vaccine perceptions were compared by SARS-CoV-2-infection and vaccination status using Pearson’s chi-squared, alpha=5%. RESULTS: Between April-May 2021, 115 individuals completed the one-year follow-up. Table 1 includes sociodemographic characteristics of adults, of which the majority were vaccinated and were unemployed or in non-essential occupations. Most individuals agreed the SARS-CoV-2 vaccine can prevent infection and hospitalization (Figure 1A & B). Unvaccinated participants more often agreed that those who contracted SARS-CoV-2 should not receive the vaccine (30%), whereas vaccinated persons less often agreed (11%, p< 0.001) (Figure 1A). Additionally, 44% of unvaccinated individuals were neutral or disagreed that benefits of SARS-CoV-2 vaccination outweighed the illness risk, compared to 10% in the vaccinated group, p=0.001 (Figure 1A). Minimal differences of vaccine perceptions were observed between SARS-CoV-2 positive and negative adults (Figure 1B). Table 1. Sociodemographic Characteristics of Adults [Image: see text] Figure 1. Vaccine perceptions of vaccinated and unvaccinated (A) SARS-CoV-2 positive and SARS-CoV-2 negative (B) adults in greater Nashville, TN. Vaccine perceptions were collected through a standardized survey at the one-year visit. [Image: see text] CONCLUSION: Although some unvaccinated individuals seemingly perceived the SARS-CoV-2 vaccine offered some protection, research should continue to evaluate the implications of vaccine hesitancy on the COVID-19 pandemic response as we prepare for the upcoming respiratory season. DISCLOSURES: Natasha B. Halasa, MD, MPH, Genentech (Other Financial or Material Support, I receive an honorarium for lectures - it's a education grant, supported by genetech)Quidel (Grant/Research Support, Other Financial or Material Support, Donation of supplies/kits)Sanofi (Grant/Research Support, Other Financial or Material Support, HAI/NAI testing) Natasha B. Halasa, MD, MPH, Genentech (Individual(s) Involved: Self): I receive an honorarium for lectures - it's a education grant, supported by genetech, Other Financial or Material Support, Other Financial or Material Support; Sanofi (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support Oxford University Press 2021-12-04 /pmc/articles/PMC8644308/ http://dx.doi.org/10.1093/ofid/ofab466.779 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Abstracts Fernandez, Kailee N Rankin, Danielle A Howe, Harrison L Bloos, Sean M Salib, Seifein Talj, Rana Rahman, Herdi Kurnia Waqfi, Danya Villarreal, Jessica Yanis, Ahmad Howard, Leigh Chappell, James Halasa, Natasha B Halasa, Natasha B 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee |
title | 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee |
title_full | 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee |
title_fullStr | 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee |
title_full_unstemmed | 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee |
title_short | 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee |
title_sort | 581. covid-19 vaccine perceptions in adults from greater nashville tennessee |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644308/ http://dx.doi.org/10.1093/ofid/ofab466.779 |
work_keys_str_mv | AT fernandezkaileen 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT rankindaniellea 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT howeharrisonl 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT bloosseanm 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT salibseifein 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT taljrana 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT rahmanherdikurnia 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT waqfidanya 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT villarrealjessica 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT yanisahmad 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT howardleigh 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT chappelljames 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT halasanatashab 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee AT halasanatashab 581covid19vaccineperceptionsinadultsfromgreaternashvilletennessee |